India's Sun Pharma to sell two marketing divisions to Strides Arcolab

September 19, 2015 8:52 AM

10 0

MUMBAI, Sept 19 Sun Pharmaceutical Industries Ltd, India's top drugmaker by sales, said on Saturday it had agreed to sell two divisions marketing central nervous system drugs to Strides Arcolab Ltd for 1.65 billion rupees ($25 million).

Sun Pharma, which last year bought domestic peer Ranbaxy Laboratories Ltd, in July said it may sell low-margin businesses it deemed do not hold long-term value.

Read more

To category page